BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3345648)

  • 1. Pseudoxanthoma elasticum (PXE): ultrastructural and biochemical study on proteoglycan and proteoglycan-associated material produced by skin fibroblasts in vitro.
    Tiozzo Costa R; Baccarani Contri M; Cingi MR; Pasquali Ronchetti I; Salvini R; Rindi S; De Luca G
    Coll Relat Res; 1988 Jan; 8(1):49-64. PubMed ID: 3345648
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of selective enzymatic digestions on skin biopsies from pseudoxanthoma elasticum: an ultrastructural study.
    Pasquali Ronchetti I; Baccarani Contri M; Pincelli C; Bertazzoni GM
    Arch Dermatol Res; 1986; 278(5):386-92. PubMed ID: 3019257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elastase digestion of normal and pseudoxanthoma elasticum lesional skin elastins.
    Schwartz E; Thieberg M; Cruickshank FA; Lebwohl M
    Exp Mol Pathol; 1991 Oct; 55(2):190-5. PubMed ID: 1936214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteoglycan alterations in skin fibroblast cultures from patients affected with pseudoxanthoma elasticum.
    Passi A; Albertini R; Baccarani Contri M; de Luca G; de Paepe A; Pallavicini G; Pasquali Ronchetti I; Tiozzo R
    Cell Biochem Funct; 1996 Jun; 14(2):111-20. PubMed ID: 8640951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical identification of abnormal constituents in the dermis of pseudoxanthoma elasticum patients.
    Baccarani-Contri M; Vincenzi D; Cicchetti F; Mori G; Pasquali-Ronchetti I
    Eur J Histochem; 1994; 38(2):111-23. PubMed ID: 7524808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cysteine protease characteristics of the proteoglycanase activity from normal and pseudoxanthoma elasticum (PXE) fibroblasts.
    Gordon SG; Hinkle LL; Shaw E
    J Lab Clin Med; 1983 Sep; 102(3):400-10. PubMed ID: 6350511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for increased protease activity secreted from cultured fibroblasts from patients with pseudoxanthoma elasticum.
    Gordon SG; Overland M; Foley J
    Connect Tissue Res; 1978; 6(1):61-8. PubMed ID: 149650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural characterization of the skin glycosaminoglycans in patients with pseudoxanthoma elasticum.
    Maccari F; Volpi N
    Int J Dermatol; 2008 Oct; 47(10):1024-7. PubMed ID: 18986348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mineralization of elastic fibers and alterations of extracellular matrix in pseudoxanthoma elasticum. Ultrastructure, immunocytochemistry, and X-ray analysis.
    Walker ER; Frederickson RG; Mayes MD
    Arch Dermatol; 1989 Jan; 125(1):70-6. PubMed ID: 2910208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal phenotype of in vitro dermal fibroblasts from patients with Pseudoxanthoma elasticum (PXE).
    Quaglino D; Boraldi F; Barbieri D; Croce A; Tiozzo R; Pasquali Ronchetti I
    Biochim Biophys Acta; 2000 Apr; 1501(1):51-62. PubMed ID: 10727849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical analyses of macromolecular matrix components in patients with pseudoxanthoma elasticum.
    Sakuraoka K; Tajima S; Nishikawa T; Seyama Y
    J Dermatol; 1994 Feb; 21(2):98-101. PubMed ID: 8182219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibroblasts from patients affected by Pseudoxanthoma elasticum exhibit an altered PPi metabolism and are more responsive to pro-calcifying stimuli.
    Boraldi F; Annovi G; Bartolomeo A; Quaglino D
    J Dermatol Sci; 2014 Apr; 74(1):72-80. PubMed ID: 24461675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracutaneous ultrastructural alterations in pseudoxanthoma elasticum.
    Gheduzzi D; Sammarco R; Quaglino D; Bercovitch L; Terry S; Taylor W; Ronchetti IP
    Ultrastruct Pathol; 2003; 27(6):375-84. PubMed ID: 14660276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum factors from pseudoxanthoma elasticum patients alter elastic fiber formation in vitro.
    Le Saux O; Bunda S; VanWart CM; Douet V; Got L; Martin L; Hinek A
    J Invest Dermatol; 2006 Jul; 126(7):1497-505. PubMed ID: 16543900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dermal fibroblasts from pseudoxanthoma elasticum patients have raised MMP-2 degradative potential.
    Quaglino D; Sartor L; Garbisa S; Boraldi F; Croce A; Passi A; De Luca G; Tiozzo R; Pasquali-Ronchetti I
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):42-7. PubMed ID: 15955448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix Gla protein is involved in elastic fiber calcification in the dermis of pseudoxanthoma elasticum patients.
    Gheduzzi D; Boraldi F; Annovi G; DeVincenzi CP; Schurgers LJ; Vermeer C; Quaglino D; Ronchetti IP
    Lab Invest; 2007 Oct; 87(10):998-1008. PubMed ID: 17724449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrophosphates as a major inhibitor of matrix calcification in Pseudoxanthoma elasticum.
    Dabisch-Ruthe M; Kuzaj P; Götting C; Knabbe C; Hendig D
    J Dermatol Sci; 2014 Aug; 75(2):109-20. PubMed ID: 24907773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonlinear optical microscopy is a novel tool for the analysis of cutaneous alterations in pseudoxanthoma elasticum.
    Kiss N; Fésűs L; Bozsányi S; Szeri F; Van Gils M; Szabó V; Nagy AI; Hidvégi B; Szipőcs R; Martin L; Vanakker O; Arányi T; Merkely B; Wikonkál NM; Medvecz M
    Lasers Med Sci; 2020 Oct; 35(8):1821-1830. PubMed ID: 32372237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pseudoxanthoma elasticum. Biochemical and ultrastructural studies.
    Pasquali-Ronchetti I; Volpin D; Baccarani-Contri M; Castellani I; Peserico A
    Dermatologica; 1981; 163(4):307-25. PubMed ID: 7308552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillin immunofluorescence in pseudoxanthoma elasticum.
    Godfrey M; Cisler J; Geerts ML; Christiano A; Uitto J; De Bie S; DePaepe A
    J Am Acad Dermatol; 1995 Apr; 32(4):589-94. PubMed ID: 7896947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.